Publications in collaboration with researchers from Memorial Sloan Kettering Cancer Center (3)

2024

  1. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

    Nature, Vol. 629, Núm. 8013, pp. 919-926

  2. In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma

    Cell Reports Medicine, Vol. 5, Núm. 8

2017

  1. A Braf kinase-inactive mutant induces lung adenocarcinoma

    Nature, Vol. 548, Núm. 7666, pp. 239-243